Fujifilm partners Shanghai firm to seek China’s approval for Covid-19 drug
TOKYO: Japan’s Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat Covid-19 and influenza.
Carelink will use Fujifilm’s data on Avigan’s treatment of novel coronavirus infections and influenza to seek imported drug approval in China, Fujifilm said in a statement. The two companies also plan to develop an injectable form of the drug.……
Leave a comment in Nestia App